SAB Biotherapeutics
SABS
SABS
25 hedge funds and large institutions have $3.38M invested in SAB Biotherapeutics in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
25
Holders Change
-1
Holders Change %
-3.85%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
6
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Citadel Advisors
Miami,
Florida
|
$29.9K |
2 |
2
Creative Planning
Overland Park,
Kansas
|
$20.8K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$18.7K |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$494K |
5 |
5
Renaissance Technologies
New York
|
$19.4K |